Press Releases

Press Releases

Archives

2017

2016

July 12, 2018

Anthony Esposito, Jr. Joins InClinica as Senior Director of Quality Assurance

InClinica, a global clinical CRO, announced today that Anthony J. Esposito, Jr. has been appointed Senior Director of Quality Assurance. [more]

July 11, 2018

Jeffrey Schwartz Joins InClinica as Assistant Vice President of Business Development, Americas

InClinica, a global clinical CRO, announced today that Jeffrey Schwartz has been appointed Assistant Vice President of Business Development, representing the company’s operations throughout North and South America. [more]

May 9, 2018

Todd Koch Joins InClinica as Global Trial Manager

InClinica, a global clinical CRO, announced today that Todd Koch has been appointed Global Trial Manager. In his new role, Koch will be responsible for the day-to-day leadership and management of clinical trials. [more]

April 18, 2018

Karthik Kumar Joins InClinica as Business Development Manager

In his new role, Kumar will be responsible for supporting clinical research organization sales and business development activities, generating leads, and providing customer relationship management and clinical operations management support. [more]

April 5, 2018

Julio Casoy Joins InClinica as Chief Medical Officer

Dr. Casoy has more than 20 years of experience in the pharmaceutical industry, specializing in rheumatology with a long history of work in women’s health. Before joining InClinica, he served as Senior Vice President of Medical Affairs at Turing Pharmaceuticals where he was responsible for establishing and managing medical affairs including data generation, data dissemination, compliance, and KOL management. Prior to that, he oversaw the medical affairs of various pharmaceutical companies, most notably, spending more than a decade leading Wyeth’s international medical affairs in Brazil. [more]

April 3, 2018

Donald L. Very, Jr. Joins InClinica as Chief Technical Analyst, Devices and Diagnostics

Dr. Very has more than 25 years of industry experience in device development, diagnostic and pharmaceutical assay development, and performance qualification in such diverse clinical areas as oncology, infectious disease, and metabolic disease. He is well-versed in each clinical trial step: research, development, performance validation, clinical trial design and implementation, and regulatory approval. [more]

February 5, 2018

InClinica CEO Speaks at the National Conference for Clinical Research in Israel

James Nolan discussed the global clinical trial crisis in Tel Aviv. Nolan’s lecture, titled “The Global Clinical Trial Crisis,” addressed some of the key issues hindering the success of clinical trials. He also offered guidance on how CROs can compete in this continuously changing landscape. [more]